Research and development in vascular translational science, focusing on therapeutic treatments, 3D modeling, and tissue engineering.
B
CSR Analysis score
The organization is among the top 20% of most committed organizations, excluding the top 5%, among comparable organizations.
+160,000
Total organizations analyzedAnalysis by axis
Access the detailed report with all sector benchmarks, in-depth competitive analysis and actionable recommendations.
Methodology: Score calculated according to 6 CSR themes (Carbon, Biodiversity, Circular Economy, Sustainable Investments, Governance, Social Impact)
Sources: Public data, CSR reports, documented initiatives, official databases
Last update: December 2025
This analysis is not yet available in English. Please see the French version.
Leading organizations
MRM
B
Research and advancement of scientific knowledge in the field of stem cells and regenerative medicine, facilitating the translation of discoveries into clinical practice.
ipbs-toulouse (cnrs-ut3)
B
Research and development in cancer, infection, and inflammation to improve therapeutics.
Ctibiotech
B
Development of advanced human tissues for biomedical research and pharmaceutical industry using stem cells and 3D printing technologies.
Initiatives identified among leaders
Développement d'une offre de formation
“L'IPBS propose une formation pour les chercheurs e...” - ipbs-toulouse (cnrs-ut3)Participation à une conférence sur les biopsies liquides
“ctibiotech participe à la conférence EACR sur les ...” - CtibiotechCréation d'un comité de développement durable
“L'IPBS-Toulouse a créé un comité de développement ...” - ipbs-toulouse (cnrs-ut3)56% of similar organizations communicate on CSR issues
+1794 initiatives collected from 100 similar organizations
Is your score incomplete? Update your CSR information and improve your positioning.
Claim this page
Updated data
Personalized recommendations
Access complete data, competitive analyses and actionable recommendations for your clients.
Comprehensive sector benchmarks
Competitive data
Ready-to-use reports